| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4268908 | European Urology Focus | 2016 | 12 Pages |
Abstract
Imaging of recurrent prostate cancer (PCa) is important to guide further treatment. Computed tomography, magnetic resonance imaging, and bone scintigraphy represent the current standard. Positron emission tomography, especially with cancer-specific tracers, might improve imaging of recurrent PCa in the future.
Related Topics
Health Sciences
Medicine and Dentistry
Urology
Authors
Tobias Maurer, Matthias Eiber, Stefano Fanti, Lars Budäus, Valeria Panebianco,